Cancer Medicines Forum workshop
April 5, 2024
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.
The CMF will report its observations and preliminary solutions to address treatment optimisation at a hybrid workshop at the EMA under the Auspices of the EU Belgian Presidency.
Date: Friday, 5 April 2024, 1:00-6:00 PM (CEST)
Location: European Medicines Agency, Amsterdam
Registration will close on 1 March 2024 for in-person participation and will remain open until 29 March 2024 for online participation.
Next events
Joint webinar: Patient preferences matter
January 9, 2026 @ 17:00 - 18:30
Virtual Event
LKI Vesalius Conference on Cancer Research 2026
January 18, 2026 - January 20, 2026
Leuven, Belgium
CDDF Annual Conference 2026
February 9, 2026 - February 11, 2026
Ghent, Belgium
EORTC Brain Tumour Group Spring Meeting 2026
March 5, 2026 - March 6, 2026
EORTC HQ, Brussels, Belgium
EORTC Lymphoma Group Spring Meeting 2026
March 6, 2026
Groningen, NL
